High throughput in silico identification and characterization of Plasmodium falciparum PRL phosphatase inhibitors

J Biomol Struct Dyn. 2018 Oct;36(13):3531-3540. doi: 10.1080/07391102.2017.1392365. Epub 2017 Nov 6.

Abstract

Kinases and phosphatases are involved in many essential processes in Plasmodium lifecycle. Among the identified 67 Plasmodium falciparum phosphatases, Phosphatase of Regenerating Liver (PRL) family protein homolog, PfPRL, is an essential parasite tyrosine phosphatase. PfPRL is shown to be prenylated, secreted, and involved in the host invasion process. In the present study, a structure-based high throughput in silico screening of PfPRL binders, using ChEMBL-NTD compounds lead to the identification of nine compounds based on binding energy, Lipinski rule of five, and QED score. The most of the shortlisted compounds are known to inhibit parasite growth at a concentration (EC50) ≤2 μm in in vitro P. falciparum culture assays. MD simulations were carried out on the shortlisted nine potential enzyme-inhibitor complexes to analyze specificity, stability, and to calculate the free binding energies of the complexes. The study identifies PfPRL as one of the potential drug targets for selected ChEMBL-NTD compounds that may be exploited as a scaffold to develop novel antimalarials.

Keywords: drug screening; kinases; ligand clustering; molecular dynamics; phosphatases; post-translational modifications.

MeSH terms

  • Antimalarials / pharmacology*
  • Drug Evaluation, Preclinical / methods*
  • Malaria, Falciparum / drug therapy*
  • Malaria, Falciparum / parasitology
  • Molecular Dynamics Simulation
  • Plasmodium falciparum / drug effects*
  • Plasmodium falciparum / enzymology*
  • Plasmodium falciparum / metabolism
  • Plasmodium falciparum / pathogenicity
  • Protein Binding
  • Protein Tyrosine Phosphatases / antagonists & inhibitors*
  • Protein Tyrosine Phosphatases / metabolism

Substances

  • Antimalarials
  • Protein Tyrosine Phosphatases